Background and objective: Respiratory symptoms including wheezing are common in adults with sickle cell anaemia (SCA), even in the absence of asthma. However, the prevalence of spirometry changes and respiratory symptoms in adults with SCA is unknown. Methods: Using a cross-sectional study design, we tested the hypothesis that adults with SCA (cases) would have higher rates of lower airway obstruction and wheezing than those without SCA (controls) using the American Thoracic Society Division of Lung Diseases' questionnaire. Patients were adults with SCA aged between 18 and 65 years. Controls were consecutive unselected individuals without SCA who presented to an outpatient general medicine clinic. Results: We enrolled 150 adults with SCA and 287 consecutive controls without SCA. The median age was 23.0 and 27.0 years for adults with and without SCA, respectively. Cases were more likely to report cough without a cold (35.0% vs 18.6%, P < 0.001), lower forced expiratory volume in 1 s (FEV 1 ) % predicted (70.1% vs 82.1%, P = 0.001) and lower forced vital capacity (FVC) % predicted (67.4% vs 74.9%, P = 0.001) than controls. In the multivariable model, wheezing was significantly associated with SCA status (OR = 1.69, 95% CI = 1.08-2.65, P = 0.024). Similarly, FEV 1 % predicted was significantly associated with SCA status and wheezing (P = 0.001 for both). Conclusion: Adults with SCA experience a higher rate of wheezing and impaired respiratory functions compared with controls from the same region.
INTRODUCTION
Sickle cell disease (SCD) is one of the most common genetic diseases in the world. 1 Pulmonary complications are a leading cause of morbidity and mortality in SCD. 2, 3 Studies suggest that in adults with SCD, the presence of SCD alone, in the absence of a physician diagnosis of asthma, can result in wheezing, acute chest syndrome and death. 4, 5 Studies on transgenic SCD mouse models have also provided evidence that SCD without experimental asthma is associated with airway inflammation and abnormal lung function. 6 These transgenic SCD mouse studies demonstrated heightened airway resistance in both small and large airways with and without experimental asthma. 6, 7 The SCD mouse study found histological and cytochemical evidence of airway inflammation, as well as high levels of total lymphocytes, %CD8+ T cells, granulocyte colonystimulating factor, IL-5, IL-7 and chemokine (C-X-C motif ) ligand (CXCL) 1 in bronchoalveolar fluid, and increased CD4+, CD8+ and regulatory T cells in lung tissue. 6 Other SCD mouse models studies demonstrated increased pulmonary and extra-pulmonary inflammatory responses even in the absence of allergic sensitization. 8 Despite the fact that asthma and recurrent wheezing in children and adults with SCD are associated with decreased lung function, current evidence indicates that they are distinct conditions; 9 .
Other studies have found that children with SCD have a higher rate of abnormal respiratory function. important contributor to morbidity and mortality in SCD, relatively few studies have compared the symptoms of obstructive lung disease and spirometry results in adults with and without SCD.
To determine the prevalence of asthma symptoms and obstructive lung disease in sickle cell anaemia (SCA; homozygous HbSS), we performed a crosssectional study in adults with and without SCA. Our hypothesis was that patients with SCA would have more symptoms associated with obstructive lung disease and have lower forced expiratory volume in 1 s (FEV 1 ) % predicted, forced vital capacity (FVC) % predicted and the ratio of FEV 1 to FVC (FEV 1 /FVC) less than lower limits of normal (LLN; less than fifth percentile) compared with controls without SCA from the same region. Findings supporting our hypothesis in this population would provide evidence that adults with SCA have a lung phenotype associated with more frequent occurrence of wheezing and abnormal respiratory function.
METHODS
We employed a cross-sectional study design, where we interviewed participants at Aminu Kano Teaching Hospital (AKTH) over a 19-month period (14 August 2013 to 30 February 2015). Research assistants interviewed 150 consecutive cases (adults with SCA attending the sickle specialty clinic for haematological consultation) and 287 consecutive consenting adults without SCA as controls, who were seeking advice at the general outpatient clinic. Consecutive consenting adults with SCA over 18 years of age were included as cases in this study. Patients who had undergone either Hb electrophoresis or HPLC, in addition to a clinical diagnosis of SCA, were included. To obtain a representative sample of adults without SCA, we enrolled consecutive controls (same eligibility range as cases, but without SCA) presenting to the general medical outpatient clinic, who were not known to have asthma. Controls were considered not having asthma during the study if there was no prior doctor diagnosis of asthma, usage of asthma medications or a history of symptoms suggestive of asthma. However, prior to enrolment in the study, we did not screen for asthma with history of asthma symptoms or spirometry. Ethics approval was obtained from the AKTH Ethics Committee in Kano, Nigeria (NHREC/ 21/08/2008/AKTH/EC/1233).
Additional ethics approval was obtained from of Vanderbilt University School of Medicine IRB in Nashville, TN, USA (110703).
The feasibility for our main study objective involves the precision of the estimated prevalence of asthma among patients with SCA, with precision representing our 95% CI. Assuming a 95% CI, using the following formula P AE 1:96 ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi
, where P = the probability and n = the number of enrolled subjects, to achieve a desired precision of 5.0% with 19% of enrolled subjects having our outcome of interest, we needed to enrol 237 subjects. We estimated a sample size of 250 adults per group for a total of 500. This will be sufficient to test our hypotheses with 80% power.
We used a structured questionnaire using the American Thoracic Society Division of Lung Diseases' Questionnaire (ATS-DLD-78-C). 12 The questionnaire captured participants' demographic information, medical history (e.g. respiratory symptoms and allergies), environmental factors (e.g. cooking and presence of animals in the home) and parental behaviour (e.g. smoking). Those who did not read or write in English were provided with a questionnaire in the native language (Hausa). A professional translator translated the questionnaires into Hausa.
Markers of abnormal pulmonary function
We determined percent predicted values for each subject based on their age, gender, height and race. This computation was carried out for FEV 1 , FVC and FEV 1 / FVC based on the Global Lung Initiative 2012 equations. 13 We determined abnormal results for FEV 1 , FEV 1 /FVC and FVC by comparing to their LLN. 13 We used values of FEV 1 , FVC and FEV 1 /FVC to classify pulmonary function patterns as normal, obstructive or restrictive, based on the ATS/European Respiratory Society (ATS/ERS) guidelines, in accordance with the modified algorithm based on Pellegrino et al.
14 Consequently, pulmonary function patterns were defined as follows: Normal ( A research assistant in Nigeria entered all responses into a REDCap electronic research database. The data entered were then checked for completeness and accuracy by investigators in Nigeria and Nashville, TN, USA. We validated entries into REDCap (Vanderbilt University, Nashville, TN, USA) by referring to entries in the study Questionnaire.
Chi-square test and Fisher exact test were used for categorical variables. T-test and Wilcoxon rank-sum test were used for continuous and ordinal variables, respectively. Multivariable logistic regression and linear regression were used to determine predictors of wheezing and respiratory function using age, gender and SCA to predict wheezing, and those three covariates plus wheezing to predict respiratory function. We did not include the analysis of asthma in the regression model because asthma was strongly correlated with wheezing. Only the presence of any wheezing, age, gender and the presence of SCA (yes or no) were included in the primary model.
RESULTS

Demographics
We evaluated 437 persons, 150 persons with SCA (cases), confirmed by electrophoresis and 287 adults without SCA (controls). The median age was 23.0 and 27.0 years for adults with SCA and without SCA (controls), respectively. The study group consisted of 47% and 31% of males among patients with and without SCA, respectively. We used the three questions about wheezing -(wheeze after exercise, shortness of breath leading to wheezing and wheezing without a cold) -to create a composite indicator of whether 'any wheezing' is present. A total of 32.4% of all study participants had some wheezing. Among the patients with SCA, 38.3% and 29.1% among controls had any wheeze (P = 0.046). During the study, presence of asthma based on a history of physician diagnosis, was noted in 8.7% of all participants, 11.8% in the controls and 2.7% in the subjects. This was compared with the patient's asthma report, and there was agreement for all but four participants.
Respiratory symptoms and lung function abnormalities
Wheezing symptoms and low FEV 1 % predicted and FVC% predicted were more common in patients with SCA than in the controls. Adults with SCA reported higher rates of cough without a cold (36.0% vs 18.6%, P < 0.001) and wheezing for any reason than those without SCA. Also, adults with SCA were more likely to have lower FEV 1 % predicted (71.3% vs 82.1%, P = 0.001) and lower FVC% predicted (67.2% vs 74.9%, P = 0.001) than those without SCA. Adults with SCA had less diagnosed asthma (11.8% vs 2.7%, P = 0.001). There were no statistically significant differences for phlegm without a cold, wheeze without a cold, shortness of breath from wheezing and wheeze after exercise in patients with SCA when compared with those without SCA (Table 1) . In a multivariable logistic regression, any wheezing was significantly associated with SCA even after adjusting for gender and age (OR = 1.69, P = 0.022; Table 2 ).
Risk factors for low FEV 1 % predicted and FEV 1 < LLN
Decreased FEV 1 % predicted was associated with a diagnosis of SCA and history of any wheezing. Using multivariable analysis, both the diagnosis of SCA and the presence of any wheezing were negatively associated with FEV 1 % predicted as a continuous covariate (P < 0.001 for both) and FEV 1 < LLN as a categorical covariate (P < 0.001 and P = 0.001, respectively, Tables 3,4) .
Risk factors for low FVC% predicted and FVC < LLN
Similar to FEV 1 % predicted, both SCA and history of any wheezing were associated with low FVC% predicted as a continuous covariate (P = 0.001 and 0.018, respectively, Table 3 ). Only SCA was significantly associated with FVC < LLN (P = 0.002; Table 4 ). No association was identified between FEV 1 /FVC% predicted and SCA (P = 0.479; Table 3 ).
DISCUSSION
In multicentre and single centre prospective observation cohort studies, a diagnosis of asthma 15 or a history of recurrent wheezing 4, 10 have been associated with an increase in the rate of mortality and morbidity in children and adults with SCA. However, what is not well established is whether adults with SCA have disproportionately higher rates of wheezing and respiratory function impairment compared with adults without SCA.
To our knowledge, this is the largest and most comprehensive study supporting our hypothesis that adults with SCA have more symptoms associated with obstructive lung disease and lower pulmonary function when compared with contemporary controls identified from the same region. Our findings are similar to that of a prior study which demonstrated that children with SCA have higher rates of wheezing when compared with contemporary controls of children without SCA. 16 Collectively, these results indicate that recurrent wheezing is more common in children and adults with SCA and, in adults, recurrent wheezing is associated with an increased prevalence of abnormal lung function. Specifically, we demonstrated that the diagnosis of SCA is an independent risk factor for wheezing and impaired respiratory function (low FEV 1 % predicted, low FVC% predicted and a higher proportion of patients with FEV 1 and FVC% predicted < LLN). Other studies have also found significantly lower respiratory function parameters among adults with SCA compared with controls. Vendramini et al. studied 26 adults with SCA and 28 controls and found significantly lower respiratory function parameters in adults with SCA compared with controls. Additionally, they found obstructive respiratory pattern (low FEV 1 /FVC predicted) and reduced diffusing lung capacity for carbon monoxide (DLCO) in all SCA cases. 17 Knight-Madden et al. also found asthma and bronchial hyperactivity (BHR) to be more common in children with SCA than in controls. 10 However, all prior studies were small, resulting in wide CIs supporting their conclusion. The strength of this study lies in the large number of cases and controls studied from the same environment within the same period.
We did not find evidence that patients with SCA had a higher rate of obstructive lung disease (FEV 1 /FVC < LLN) when compared with the controls, despite the history of asthma symptoms. We can only postulate why adults with SCA do not have a higher rate of a spirometry-confirmed obstructive lung disease. Possibilities include that recurrent small airway obstruction might lead to long-term lung fibrosis. 18 Perhaps, the finding of lower than expected FEV 1 and FVC in adults with SCA, but with a normal FEV 1 /FVC, may suggest intrinsic lung disease that was not measured. Only when lung volumes are measured and a prospective study with serial pulmonary function assessments is done in this population, would we be able to better identify the cause of a normal FEV 1 /FVC.
In an attempt to assess the preceding occurrence of certain clinically important events related to asthma, we relied on participants' statements. This carried an inherent challenge of recall bias. While it is difficult to be certain of reported asthma status, we utilized validated questionnaire to address asthma symptoms and used a composite symptom of: any wheeze for purpose of analysis. The median age of participants with SCA was that of a young adult population; however, this would tend to be associated with better lung function. Nevertheless, the association between SCA with wheezing and impaired lung function parameters remained significant even after adjusting for age. The predominant sickle cell disease phenotype in Northern Nigeria is that of HbSS gene. There are few HbSC variants in southern Nigeria. The HbSC gene may also present with a less severe clinical manifestation. We did not screen controls with Hb electrophoresis or HPLC to determine if they were carriers of the SCD mutation; however, study participants were adults, who would have manifested clinical features of SCA, if they harboured the gene.
While we used spirometry alone to define lung function abnormalities, several other studies used total lung capacity (TLC) and DLCO. 10, 17 Spirometry has the advantage of ease of usage; however, the use of fixed values for PFT parameters can lead to misclassification, with young persons classified as 'normal' while indeed they had obstructive lung disease. To address this limitation, our primary hypothesis was focused on obstructive symptoms and corresponding PFT results associated with obstruction, namely FEV 1 % predicted and FEV 1 /FVC and not restrictive lung disease. The findings of our study could be generalized to adults with SCA in other settings. However, it may not apply to adults with other variants of SCD, because of the differences in induced lung-specific immunepathogenic changes.
In summary, adults with SCA experience a remarkably higher rate of wheezing and impaired FEV 1 % predicted and FVC% predicted compared with contemporary controls identified from the same region. The presence of SCA was the most likely explanation for the higher rate of asthma symptoms and lower respiratory function when compared with controls. Asthma risk factors alone do not appear to account for the higher rate of wheezing. The association between lower lung function and future morbidity and mortality may be an important consideration to provide better risk stratification for understanding the natural history of lung disease, and ultimately targeted therapy. 
